APASL consensus statements and recommendation on treatment of hepatitis C

Masao Omata, Tatsuo Kanda, Lai Wei, Ming Lung Yu, Wang Long Chuang, Alaaeldin Ibrahim, C. Rinaldi Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geofferey W. McCaughan, Jafri Wasim, Darrell H.G. Crawford, Jia Horng Kao, Osamu Yokosuka, George K.K. LauShiv Kumar Sarin

Research output: Contribution to journalReview articlepeer-review

161 Citations (Scopus)

Abstract

The Asian-Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL consensus statements and recommendation on management of hepatitis C” in March, 2015, in order to revise “APASL consensus statements and management algorithms for hepatitis C virus infection (Hepatol Int 6:409–435, 2012)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations on treatment of hepatitis C are presented in this review.

Original languageEnglish
Pages (from-to)702-726
Number of pages25
JournalHepatology International
Volume10
Issue number5
DOIs
Publication statusPublished - 1 Sep 2016

Keywords

  • APASL
  • DAAs
  • HCV
  • Interferon-free
  • Turkey

Fingerprint

Dive into the research topics of 'APASL consensus statements and recommendation on treatment of hepatitis C'. Together they form a unique fingerprint.

Cite this